Epilepsy Market Size

Epilepsy Market size was valued at USD 681.41 million in 2024 and is likely to exceed USD 1.69 billion by the end of 2037, registering over 7.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of epilepsy is evaluated at USD 721.2 million.. The major factor attributed to the growth of the global market is the rising prevalence of epilepsy among the global population and increasing cases of neurological diseases around the globe. According to data from the World Health Organization (WHO), around 50 million people worldwide have epilepsy.

In addition to the aforementioned factors, the other factors responsible for significant revenue generation in the next few years are the surge of non-communicable diseases along with central nervous system disorders. Apart from it, the escalation in abnormal brain activities such as seizures, episodes of involuntary movements, and sensations owing to prenatal or perinatal complications, congenital abnormalities, or genetic conditions are considered to impetus the growth of the market size during the forecast period. In addition, numerous initiatives taken by governments and organizations to spread awareness about epilepsy are also estimated to provide growth opportunities for the expansion of the global epilepsy market in the coming years. Furthermore, the increasing geriatric population coupled with the presence of a strong healthcare base and rising healthcare expenditure are also attributed to creating a positive outlook for market growth during the forecast period. Moreover, the growing awareness amongst people regarding the treatment of neurological diseases, combined the with high adoption of antiepileptic drugs (AEDs) is also estimated to drive market growth.